Results expressed as mean _+ SEM globulin levels are not raised during the first 24 h of coma treatment. In view of the depressing effect of antiplatelet agents on prostaglandin I2 synthesis and renal blood flow [3] , drugs, such as aspirin, appear to be contra-indicated in ketoacidosis. Since thromboembolic complications during diabetic coma occur more commonly in elderly patients, in circulatory shock, and in hyperosmolar, non-ketotic coma [4, 5] , heparin treatment may be indicated in such high risk patients. However, we would argue that there is no rationale for antiplatelet drugs in diabetic ketoacidosis. [1] ; in the heart Van der Geld [21 demonstrated cardiac antibodies after myocardial infarction or cardiotomy; and these have also been described in patients with idiopathic hypertrophic subaortic stenosis [3] . In the exocrine pancreas several early investigations have detected antibodies to pancreatic antigens in patients with chronic pancreatic disease and animals with experimentally induced pancreatitis [4] [5] [6] [7] .
In juvenile insulin-dependent diabetic patients islet cell antibodies can be demonstrated in the majority of patients at the time of diagnosis, but thereafter are seen to decline. This transient pattern of auto-antibody production is not typical of the situation usually seen in organspecific auto-immune disease, where antibodies tend to be persistent. We therefore decided to investigate whether, by analogy with the conditions described above, trauma to the pancreas per se could induce the appearance of islet cell antibodies.
We therefore investigated the presence of islet cell antibodies in 21 random subjects, not suspected of being diabetic, who were undergoing endoscopic retrograde cholangio pancreatography. Investigations were carried out for 6 weeks following the procedure. Islet cell antibodies were looked for by both the 1 gG and C3 techniques. Thirty-four random blood donor specimens were examined over the same period.
All the sera from the 21 subjects were uniformly negative for islet cell antibodies pre-and post-endoscopic retrograde cholangio pancreatography. Anti-nuclear antibodies were present in two patients throughout the investigation. After endoscopic retrograde cholangio pancreatography, exocrine staining, similar to that described by Lendrum and Walker [7] , was noted in some patients. All blood donor control subjects were negative for islet cell antibodies.
Endoscopic retrograde cholangio pancreatography may lead to a transient rise in serum amylase [8] , have rightly drawn attention to our limited ability to predict metabolic deterioration in subjects with impaired glucose tolerance. Our own experience is similar [1] .
Subjects with impaired tolerance are a heterogeneous group and their behaviour, which may have many determinants, is variable. Their final two sentences require some comment, however. Firstly, not everyone would agree that impaired glucose tolerance is not to be equated with 'early diabetes' [2] .
How many are a 'few'? Depending on criteria used, at least 8.9% and at worst 52.5% of a group of female chemical diabetic patients (impaired glucose tolerance) were calculated to deteriorate over a 10 year period -and this in a group who had already had at least one normal glucose tolerance test as a condition of entry to the study [3] . Forty-five percent deteriorated to overt diabetes over 10 years in the Birmingham study [4] , 59% of a group with fasting blood glucose > 6 mmol/l deteriorated to an undefined level over 23 years [5] and 29% became diabetic over 10 years in a Swedish study [6] . Professor Keen himself reports that 15% deteriorate to diabetes in 10 years, but if obese at baseline, this rises to 19.5%. (This is already higher than one might expect from the previously reported 8.5% over 8.5 years in the same Bedford population [7] ).
Recently Fajans [8] has reported that asymptomatic kindred of known maturity onset diabetes of the young subjects with normal or impaired glucose tolerance deteriorate slowly to diabetes (up to 24 years). Eighty percent (12/!5) with impaired glucose tolerance progressed to diabetes. As a consequence, although the incidence may be low, the eventual prevalence of diabetes may be high.
From the above studies, 29% 59% is a significant minority in whom impaired glucose tolerance does appear to equate with 'early diabetes'. These people will have considerable influence upon the use of expensive health care facilities and their early recognition may allow successful intervention [6] .
Finally, in our enthusiasm to state the case that the majority of subjects with impaired glucose tolerance may not have a progressive condition, we must not lose sight that a diagnosis of impaired glucose tolerance does carry risks in its own right, e. g. for coronary heart disease [9] and that subjects with impaired glucose tolerance are as a group 'at risk' of metabolic deterioration and require careful follow-up.
Yours sincerely, W.J. Mutch and J. M. Stowers
